Top 23 Pharmaceuticals Companies in Puerto Rico
Top 23 Pharmaceuticals Companies in Puerto Rico
The pharmaceuticals industry in Puerto Rico is a cornerstone of the island's economy, characterized by a mix of research-driven firms and large-scale manufacturers. These companies produce a wide range of pharmaceutical products, including generics, biologics, and over-the-counter medications. Significant investment in R&D reflects an emphasis on innovation, particularly in fields such as oncology and rare diseases. As more companies further integrate advanced technology and biotechnology, the industry aims to bolster its global competitiveness, creating new jobs and stimulating local growth. Puerto Rico’s strategic location offers access to both American and Latin American markets, making it a burgeoning hub for pharmaceuticals.
This list features 23 pharmaceutical companies, ranging from mid-sized firms to large corporate entities, headquartered in locations spanning the globe, including Puerto Rico, India, and Argentina. Founded between the 1930s and the early 2000s, these companies specialize in a variety of therapeutic areas, such as oncology, respiratory health, and more. While some focus on generic medication, others emphasize innovative therapies addressing unmet medical needs. Their combined workforce exceeds 40,000, highlighting the industry's significance in job creation and economic development. With ongoing investments in R&D, these companies are shaping the future of healthcare solutions.
Continue reading to explore the top pharmaceuticals companies in Puerto Rico.
Top 23 Pharmaceuticals Companies in Puerto Rico
1. Mundipharma
- Website: mundipharma.com
- Ownership type: Corporate
- Headquarters: Cambridge, England, United Kingdom (UK)
- Employee distribution: United Kingdom (UK) 27%, United Arab Emirates 6%, Brazil 5%, Other 63%
- Latest funding: June 2023
- Founded year: 1952
- Headcount: 1001-5000
- LinkedIn: mundipharma
Mundipharma International Limited, based in Cambridge, England, is a British multinational pharmaceutical company founded in 1952. The company is dedicated to research-based drug development, focusing on innovative treatments for various health conditions, including pain management, oncology, respiratory issues, and central nervous system disorders. Mundipharma's product portfolio includes well-known medications such as Targin, OxyContin, and Pelmeg, among others. The company operates globally, emphasizing collaboration and partnerships to enhance patient care. With approximately 2,131 employees, Mundipharma has a significant presence in markets such as the United Kingdom, United Arab Emirates, Brazil, and Singapore. Recently, they sold their Consumer Health business to concentrate on their prescription portfolio, indicating a strategic shift towards strengthening their specialty care business. This focus on prescription medications aligns with their mission to provide effective pharmaceutical solutions to healthcare professionals and patients alike.
2. Intas Pharmaceuticals
- Website: intaspharma.com
- Ownership type: Private Equity
- Headquarters: Ahmedabad, Gujarat, India
- Employee distribution: India 99%, Other 1%
- Latest funding: October 2022
- Founded year: 2000
- Headcount: 10001+
- LinkedIn: intas-biopharmaceuticals
Intas Pharmaceuticals Limited, based in Ahmedabad, Gujarat, India, is a private equity-owned pharmaceutical company that specializes in the development, manufacturing, and marketing of generic therapeutic drugs. Founded in 2000, Intas has grown significantly, employing over 17,000 people and serving healthcare professionals in more than 85 countries. The company is dedicated to addressing unmet medical needs through innovative products and a strong commitment to quality. Intas has a comprehensive product portfolio that includes a wide range of formulations, from tablets to injectables. Their R&D efforts are robust, with a dedicated team of over 550 scientists and researchers working in advanced facilities. Intas is also recognized for its capabilities in biosimilars and has established a plasma fractionation center, further enhancing its position in the pharmaceutical sector. The company has received various global regulatory approvals, ensuring that its products meet high international standards.
3. Laboratorios Bagó
- Website: bago.com.ar
- Ownership type: Private
- Headquarters: General Pacheco, Buenos Aires, Argentina
- Employee distribution: Argentina 70%, Brazil 6%, Ecuador 4%, Other 19%
- Founded year: 1934
- Headcount: 5001-10000
- LinkedIn: laboratorios_bago
Laboratorios Bagó is a private pharmaceutical company based in General Pacheco, Buenos Aires, Argentina. Founded in 1934, it has grown to employ between 5,001 and 10,000 people, with a significant portion of its workforce located in Argentina. The company specializes in the development and manufacturing of prescription and over-the-counter medications, focusing on innovative healthcare solutions. Laboratorios Bagó is committed to quality and excellence, operating in over 50 countries and serving healthcare professionals, hospitals, and patients. Its research and development efforts are notable, with a strong emphasis on creating original molecules and drug formulations. The company has established a reputation for scientific rigor and therapeutic effectiveness, making its products well-regarded in the markets it serves.
4. Polpharma
- Website: polpharma.pl
- Ownership type: Private
- Headquarters: Poland
- Employee distribution: Poland 92%, Ukraine 2%, Other 6%
- Founded year: 1935
- Headcount: 1001-5000
- LinkedIn: polpharma
Polpharma is a prominent pharmaceutical company based in Poland, established in 1935. It specializes in the production of medicines and healthcare solutions, focusing on developing safe and effective products for patients, healthcare providers, and hospitals. With a workforce of over 2,500 employees, Polpharma operates multiple production facilities and research centers, emphasizing innovation in drug development. The company is particularly known for its contributions to the Polish pharmaceutical market, where it holds a significant share, supplying a substantial portion of medications available in pharmacies and hospitals. Polpharma is also involved in various therapeutic areas, including ophthalmic drugs and treatments for chronic conditions. Their commitment to corporate social responsibility and ethical practices further enhances their standing in the industry.
5. PharmEvo Private Limited
- Website: pharmevo.biz
- Ownership type: Private
- Headquarters: Karachi, Sindh, Pakistan
- Employee distribution: Pakistan 96%, Other 4%
- Founded year: 1999
- Headcount: 1001-5000
- LinkedIn: pharmevo-pvt--ltd
PharmEvo Private Limited, founded in 1999 and based in Karachi, Pakistan, is a pharmaceutical company dedicated to the development, manufacturing, and marketing of innovative healthcare products. With a workforce of approximately 1,910 employees, PharmEvo serves healthcare professionals, hospitals, and patients by providing high-quality medications and solutions. The company places a strong emphasis on research and development, aiming to enhance patient safety and health outcomes. PharmEvo operates a state-of-the-art manufacturing facility that adheres to international best practices. Their initiatives include pharmacovigilance to monitor drug safety, as well as various community engagement programs aimed at improving public health awareness. PharmEvo's commitment to ethical practices and socially responsible marketing further solidifies its role in the pharmaceutical industry.
6. MSD Sharp & Dohme GmbH
- Website: msd.de
- Ownership type: Private
- Headquarters: Amt Neuhaus, Lower Saxony, Germany
- Founded year: 2001
- Headcount: 1001-5000
- LinkedIn: msd-sharp-%26-dohme-gmbh
MSD Sharp & Dohme GmbH, a subsidiary of Merck & Co., Inc., is a pharmaceutical company based in Amt Neuhaus, Lower Saxony, Germany. Founded in 2001, the company specializes in the research, development, and manufacturing of innovative medications and vaccines. MSD is particularly focused on addressing health challenges in oncology and infectious diseases, striving to enhance treatment options and improve patient outcomes. The company serves healthcare providers, hospitals, and patients, emphasizing the importance of accessible healthcare solutions. With a workforce of approximately 2,438 employees, MSD is recognized as one of the major pharmaceutical manufacturers in Germany, contributing significantly to the healthcare landscape. Their ongoing research efforts and commitment to clinical trials reflect their dedication to advancing medical science and improving global health.
7. Eskayef Pharmaceuticals Ltd.
- Website: skfbd.com
- Ownership type: Private
- Headquarters: Dhaka, Dhaka, Bangladesh
- Employee distribution: Bangladesh 100%
- Founded year: 1990
- Headcount: 5001-10000
- LinkedIn: eskayef-pharmaceuticals-limited
Eskayef Pharmaceuticals Ltd., founded in 1990, is a private pharmaceutical company based in Dhaka, Bangladesh. It specializes in the manufacture and marketing of therapeutic drugs and health products. The company serves healthcare providers and patients by offering high-quality medications, including treatments for COVID-19. Eskayef operates globally, exporting its products to over 70 countries. The company has made significant investments in research and development, ensuring that it stays at the forefront of pharmaceutical innovation. Eskayef is recognized for its ethical business practices and has received numerous accreditations from international regulatory authorities, including the US FDA and UK MHRA. This commitment to quality and safety is reflected in its extensive product range, which includes oncology and animal health products. Eskayef's facilities are equipped with advanced technology, enabling the production of premium quality medicines that meet global standards.
8. Seattle Genetics
- Website: seattlegenetics.com
- Ownership type: Private
- Headquarters: Bothell, Washington, United States (USA)
- Founded year: 1998
- Headcount: 1001-5000
- LinkedIn: seattle-genetics
Seattle Genetics, founded in 1998 and based in Bothell, Washington, is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for cancer. The company is particularly known for its pioneering work in antibody-drug conjugates (ADCs), which combine targeted therapy with chemotherapy to improve treatment outcomes for patients with various types of cancer. Seattle Genetics has successfully brought several products to market, including Adcetris, which is used to treat certain lymphomas. Their commitment to research and development is evident in their extensive pipeline of potential therapies aimed at addressing significant medical needs in oncology. With a workforce of over 2,000 employees, Seattle Genetics continues to push the boundaries of cancer treatment through scientific innovation and collaboration with healthcare providers and researchers.
9. Amoun Pharmaceutical Company
- Website: amoun.com
- Ownership type: Corporate
- Headquarters: Al Waili Al Kabir Sharq, Cairo Governorate, Egypt
- Employee distribution: Egypt 97%, Other 3%
- Latest funding: $740.0M, March 2021
- Founded year: 1998
- Headcount: 1001-5000
- LinkedIn: amoun-pharmaceutical-industries-company
Amoun Pharmaceutical Company S.A.E. is an Egyptian joint-stock company established in 1998, headquartered in El Obour City, Egypt. The company specializes in the development, manufacturing, marketing, and distribution of pharmaceutical products. With a workforce of over 2,500 employees, Amoun operates one of the largest pharmaceutical manufacturing facilities in Africa and the Middle East, utilizing advanced technology to ensure product quality and safety. The company has a strong commitment to research and development, continuously optimizing its processes to meet evolving healthcare demands. Amoun's product range includes over 230 registered medications, catering to various therapeutic areas. The company has also expanded its reach, exporting products to more than 29 countries. In 2021, Amoun was acquired by Abu Dhabi Developmental Holding Company (ADQ), which has further strengthened its position in the market. The company reported impressive sales growth, achieving 5.7 billion Egyptian Pounds in 2023, showcasing its operational success and market influence.
10. ViiV Healthcare
- Website: viivhealthcare.com
- Ownership type: Private
- Headquarters: London, England, United Kingdom (UK)
- Employee distribution: United States (USA) 48%, United Kingdom (UK) 20%, Spain 6%, Other 26%
- Founded year: 2009
- Headcount: 501-1000
- LinkedIn: viiv-healthcare
ViiV Healthcare, founded in 2009 and headquartered in London, is a pharmaceutical company dedicated to the research and development of innovative medicines specifically for the treatment and prevention of HIV/AIDS. With a workforce of approximately 1,882 employees, the company operates primarily in the United States and the United Kingdom, with additional presence in several European countries. ViiV Healthcare is committed to improving the lives of individuals living with HIV by providing effective treatment options and engaging in community support initiatives. The company is recognized for its ongoing research efforts aimed at finding new therapies and ultimately a cure for HIV. ViiV Healthcare also emphasizes the importance of bridging the gap between research and clinical practice, ensuring that advancements in HIV science translate into real-world benefits for patients. Its initiatives extend beyond medicine, focusing on community engagement and addressing stigma associated with HIV, thereby fostering a supportive environment for those affected by the virus.
11. Chiesi Group
- Website: chiesi.com
- Ownership type: Private
- Headquarters: Parma, Emilia-Romagna, Italy
- Employee distribution: Italy 64%, Pakistan 3%, United Kingdom (UK) 3%, Other 30%
- Founded year: 1935
- Headcount: 5001-10000
- LinkedIn: chiesi-group
Chiesi Group, officially known as Chiesi Farmaceutici S.p.A., is an international biopharmaceutical company headquartered in Parma, Italy. With a workforce of approximately 5,751 employees, the company specializes in the research, development, and commercialization of innovative therapeutic solutions. Their primary focus areas include respiratory health, rare diseases, and specialty care, aiming to enhance the quality of life for patients worldwide. Chiesi operates in more than 100 countries, with a direct presence in 31, and maintains research and development facilities in several countries, including Italy, France, the United States, Canada, China, the United Kingdom, and Sweden. The company has made significant strides in sustainability, having adopted the status of a Benefit Corporation in 2018 and receiving B Corp certification in 2019, reaffirmed in 2022. This reflects their commitment to balancing profit with purpose, ensuring that their operations positively impact society and the environment.
12. EVA pharma
- Website: evapharma.com
- Ownership type: Private
- Headquarters: Egypt
- Employee distribution: Egypt 93%, Saudi Arabia 3%, Other 4%
- Founded year: 1997
- Headcount: 1001-5000
- LinkedIn: eva-pharma
EVA Pharma is a private pharmaceutical company based in Egypt, founded in 1997. With a workforce of over 5,000 employees, the company specializes in providing innovative healthcare solutions tailored to meet the needs of healthcare providers, hospitals, and patients. EVA Pharma operates internationally, focusing on various therapeutic areas such as oncology, neuroscience, respiratory health, and cardiometabolic medicine. The company is committed to quality and accessibility in healthcare, producing over one million packs of products daily from its three internationally accredited manufacturing facilities. With a portfolio of over 300 products and more than 500 in the pipeline, EVA Pharma is actively engaged in research and development, aiming to enhance the quality of life for patients worldwide. Their collaborations with global partners, such as Lilly and Vodafone, further illustrate their proactive approach to expanding access to essential treatments and digital health solutions.
13. Pharmasyntez Group of Companies
- Website: pharmasyntez.com
- Ownership type: Private
- Headquarters: Russia
- Employee distribution: Russia 96%, China 4%
- Founded year: 1997
- Headcount: 1001-5000
- LinkedIn: jsc-pharmasyntez
Pharmasyntez Group of Companies, founded in 1997, is a private pharmaceutical company based in Russia. The firm specializes in the development and production of medications targeting significant health issues, including tuberculosis, HIV, oncology, diabetes, hepatitis, and COVID-19. With a workforce of over 4,000 highly qualified professionals, Pharmasyntez operates five manufacturing facilities located in various cities across Russia, including Irkutsk, Ussuriysk, Tyumen, Saint Petersburg, and Bratsk. The company is dedicated to ensuring that healthcare providers and patients have access to high-quality pharmaceuticals. Their focus on modern drug production and collaboration with both domestic and international pharmaceutical companies highlights their active role in the industry. Pharmasyntez is also involved in scientific research and development, contributing to advancements in treatment options for serious health conditions.
14. Eisai Co., Ltd.
- Website: eisai.com
- Ownership type: Private
- Headquarters: Bunkyo City, Tokyo, Japan
- Employee distribution: Japan 54%, Vietnam 8%, United States (USA) 6%, Other 32%
- Founded year: 1941
- Headcount: 1001-5000
- LinkedIn: %e3%82%a8%e3%83%bc%e3%82%b6%e3%82%a4%ef%bc%88%e6%a0%aa%ef%bc%89
Eisai Co., Ltd., based in Bunkyo City, Tokyo, Japan, is a pharmaceutical company founded in 1941. The company specializes in drug discovery and development, with a strong focus on creating innovative treatments for various health conditions, particularly in oncology and neurology. Eisai is dedicated to improving patient outcomes and enhancing access to medicines through its extensive research and development efforts. The company operates globally, with a significant presence in Japan, Vietnam, the United States, and other countries. Eisai's commitment to sustainability and initiatives aimed at improving access to medicines for non-communicable diseases and neglected tropical diseases highlight its role in addressing global health challenges. Their recent advancements, such as the approval of Leqembi for Alzheimer's disease, demonstrate their ongoing contributions to the pharmaceutical field.
15. Opsonin Pharma Ltd
- Website: opsonin-pharma.com
- Ownership type: Private
- Headquarters: Dhaka, Dhaka, Bangladesh
- Employee distribution: Bangladesh 99%
- Founded year: 1956
- Headcount: 5001-10000
- LinkedIn: opsonin-pharma
Opsonin Pharma Ltd, based in Dhaka, Bangladesh, is a pharmaceutical company that has been operational since 1956. The company focuses on the development, manufacturing, and marketing of generic medicines for human use. With a commitment to enhancing healthcare quality, Opsonin Pharma offers a wide range of pharmaceutical products, including over 350 brands and more than 800 SKUs. The company also produces agrovet products, catering to the agricultural sector. Opsonin Pharma has made significant strides in expanding its global footprint, exporting its products to approximately 25 countries, including regions in Asia, Africa, and the Middle East. The company adheres to international regulatory standards, ensuring that its manufacturing processes meet the requirements of bodies such as the US-FDA and EU. Opsonin Pharma's mission is to provide affordable and quality healthcare solutions, making it a vital contributor to the pharmaceutical landscape in Bangladesh and beyond.
16. MSD Switzerland
- Website: msd.ch
- Ownership type: Private
- Headquarters: Lucerne, Lucerne, Switzerland
- Employee distribution: Switzerland 96%, Germany 4%
- Founded year: 1963
- Headcount: 1001-5000
- LinkedIn: msdswitzerland
MSD Merck Sharp & Dohme AG, based in Lucerne, Switzerland, is a biopharmaceutical company established in 1963. The company is dedicated to the discovery and development of innovative medications and vaccines aimed at addressing critical health challenges. MSD Switzerland focuses on key therapeutic areas such as oncology, infectious diseases, and diabetes, providing healthcare providers and patients with essential treatments. The company operates with a strong emphasis on scientific research and development, conducting numerous clinical studies to advance their pipeline of products. MSD Switzerland is also recognized for its commitment to corporate responsibility, engaging in initiatives that enhance healthcare access and support local projects. With a workforce of over 500 employees, MSD Switzerland plays a significant role in the pharmaceutical sector, contributing to the health and well-being of the population.
17. Cadila Pharmaceuticals Limited
- Website: cadilapharma.com
- Ownership type: Corporate
- Headquarters: Ahmedabad, Gujarat, India
- Employee distribution: India 97%, Other 3%
- Latest funding: September 2021
- Founded year: 1951
- Headcount: 5001-10000
- LinkedIn: cadila-pharmaceuticals
Cadila Pharmaceuticals Limited, based in Ahmedabad, Gujarat, India, is a corporate entity with a workforce of over 8,300 employees. Established in 1951, the company specializes in the production of a wide range of pharmaceutical products, including active pharmaceutical ingredients (APIs), finished formulations, and biotechnology products. Cadila is dedicated to providing affordable and innovative medical solutions, aiming to improve health outcomes for patients globally. The company operates with a strong emphasis on research and development, employing around 350 scientists to tackle complex diseases and develop new therapies. Cadila's manufacturing facilities comply with stringent international standards, ensuring quality and safety in its products. With a presence in over 100 countries, Cadila Pharmaceuticals is committed to making healthcare accessible and effective for all.
18. Laboratório Cristália
- Website: cristalia.com.br
- Ownership type: Private
- Headquarters: Itapira, Sao Paulo, Brazil
- Employee distribution: Brazil 100%
- Founded year: 1972
- Headcount: 5001-10000
- LinkedIn: laboratoriocristalia
Laboratório Cristália, based in Itapira, São Paulo, Brazil, is a private pharmaceutical and biotechnology company founded in 1972. The company specializes in the development and manufacturing of a wide array of medications, with a notable emphasis on anesthetics and biological products. Cristália serves hospitals, healthcare providers, and patients, focusing on innovative therapies and robust research and development efforts to improve healthcare outcomes. With a workforce of approximately 3,778 employees, the company operates entirely within Brazil and has built a reputation for its commitment to quality and innovation. Cristália boasts a portfolio of around 350 medications available in over 500 pharmaceutical presentations, and it has secured 129 patents, showcasing its dedication to advancing medical science. The company also invests about 8% of its annual revenue into research and development, indicating a strong focus on innovation and the creation of new therapies.
19. Aristopharma Ltd.
- Website: aristopharma.com
- Ownership type: Private
- Headquarters: Dhaka, Dhaka, Bangladesh
- Employee distribution: Bangladesh 84%, India 7%, Myanmar 2%, Other 6%
- Founded year: 1986
- Headcount: 1001-5000
- LinkedIn: aristopharma
Aristopharma Ltd. is a private pharmaceutical company based in Dhaka, Bangladesh, founded in 1986. The company specializes in the manufacturing of a wide range of medicines, including antiulcerants, antibiotics, and herbal products. With a workforce of approximately 602 employees, Aristopharma is dedicated to improving health outcomes in the community by providing affordable and quality healthcare solutions. The company operates two manufacturing plants equipped with advanced facilities to meet both local and international demands. Aristopharma is recognized as one of the top 10 pharmaceutical companies in Bangladesh and has established a global presence by exporting its products to 31 countries across five continents. Their commitment to quality is reflected in their rigorous quality assurance processes and ongoing research and development efforts, which aim to innovate and enhance their product offerings.
20. Douglas Pharmaceuticals
- Website: douglas.co.nz
- Ownership type: Family Owned
- Headquarters: Auckland, Auckland, New Zealand
- Employee distribution: New Zealand 88%, Fiji Islands 10%, Other 2%
- Founded year: 1967
- Headcount: 501-1000
- LinkedIn: douglas-pharmaceuticals
Douglas Pharmaceuticals, founded in 1967, is a family-owned pharmaceutical company based in Auckland, New Zealand. The company specializes in the manufacture and distribution of prescription medicines, nutraceuticals, and consumer healthcare products. With a workforce of around 631 employees, Douglas Pharmaceuticals has established a strong reputation for high-quality products and innovative solutions. They serve healthcare providers, pharmacies, and consumers, focusing on enhancing health outcomes. The company operates primarily in New Zealand and Fiji, exporting its products to 40 countries worldwide. Douglas Pharmaceuticals is also involved in contract manufacturing and has a commitment to research and development, ensuring compliance with international standards. Their dedication to quality and customer service has earned them recognition in the industry, making them a notable entity in the pharmaceutical sector.
21. Adamed Pharma
- Website: adamed.com
- Ownership type: Private
- Headquarters: Warsaw, Masovian Voivodeship, Poland
- Employee distribution: Poland 92%, Spain 3%, Other 5%
- Founded year: 1986
- Headcount: 1001-5000
- LinkedIn: adamed
Adamed Pharma S.A. is a Polish pharmaceutical and biotechnology company based in Warsaw, founded in 1986. With a workforce of over 1,500 employees, the company specializes in the development and manufacturing of high-quality medicinal products aimed at treating chronic diseases. Their product range includes prescription medications, over-the-counter drugs, dietary supplements, dermocosmetics, and medical devices. Adamed Pharma is dedicated to innovation, focusing on addressing key medical challenges across multiple therapeutic areas. The company holds approximately 250 patents in the pharmaceutical field and produces around 71 million packages annually. Their commitment to quality and safety is reflected in their continuous monitoring of pharmacotherapy and adherence to ethical standards in the industry. Adamed Pharma also engages in social responsibility initiatives, further solidifying its role in the healthcare sector.
22. GSK Canada
- Website: gsk.ca
- Ownership type: Private
- Headquarters: Mississauga, Ontario, Canada
- Founded year: 1906
- Headcount: 1001-5000
- LinkedIn: gsk-canada
GSK Canada, based in Mississauga, Ontario, is a biopharmaceutical company that has been operational since 1906. The company specializes in the development of innovative vaccines and specialty medicines aimed at addressing various health conditions. GSK Canada focuses its research and development efforts on therapeutic areas such as infectious diseases, HIV, oncology, and immunology. With a workforce of approximately 1,628 employees across Canada, GSK has made significant contributions to the healthcare sector, including over $2 billion invested in pharmaceutical and vaccine R&D since 2001. Their product portfolio includes a range of vaccines and specialty medicines, reflecting their commitment to improving health outcomes for patients and healthcare professionals alike.
23. Blau Farmacêutica
- Website: blau.com.br
- Ownership type: Private
- Headquarters: Cotia, Sao Paulo, Brazil
- Founded year: 1987
- Headcount: 1001-5000
- LinkedIn: blausiegel
Blau Farmacêutica, based in Cotia, São Paulo, Brazil, is a private pharmaceutical company established in 1987. It specializes in high-complexity medications and biotechnology solutions, primarily serving hospitals and healthcare providers across Latin America and the United States. The company is dedicated to developing innovative therapies that aim to improve patient care while reducing treatment side effects. With a robust portfolio that includes medications for oncology, hematology, immunology, and other critical areas, Blau operates several state-of-the-art manufacturing facilities. These facilities comply with rigorous international standards, ensuring the quality and safety of their products. Blau Farmacêutica is also publicly traded on the Brazilian stock exchange under the ticker "BLAU3," reflecting its significant presence in the market. The company has received numerous awards for its performance and innovation, further solidifying its position in the pharmaceutical sector.
Pharmaceuticals Insights: Key Companies in Puerto Rico
Company | Headquarter | Size | Founded | Ownership |
---|---|---|---|---|
Mundipharma | Cambridge, England, United Kingdom (UK) | 1001-5000 | 1952 | Corporate |
Intas Pharmaceuticals | Ahmedabad, Gujarat, India | 10001+ | 2000 | Private Equity |
Laboratorios Bagó | General Pacheco, Buenos Aires, Argentina | 5001-10000 | 1934 | Private |
Polpharma | Poland | 1001-5000 | 1935 | Private |
PharmEvo Private Limited | Karachi, Sindh, Pakistan | 1001-5000 | 1999 | Private |
MSD Sharp & Dohme GmbH | Amt Neuhaus, Lower Saxony, Germany | 1001-5000 | 2001 | Private |
Eskayef Pharmaceuticals Ltd. | Dhaka, Dhaka, Bangladesh | 5001-10000 | 1990 | Private |
Seattle Genetics | Bothell, Washington, United States (USA) | 1001-5000 | 1998 | Private |
Amoun Pharmaceutical Company | Al Waili Al Kabir Sharq, Cairo Governorate, Egypt | 1001-5000 | 1998 | Corporate |
ViiV Healthcare | London, England, United Kingdom (UK) | 501-1000 | 2009 | Private |
Chiesi Group | Parma, Emilia-Romagna, Italy | 5001-10000 | 1935 | Private |
EVA pharma | Egypt | 1001-5000 | 1997 | Private |
Pharmasyntez Group of Companies | Russia | 1001-5000 | 1997 | Private |
Eisai Co., Ltd. | Bunkyo City, Tokyo, Japan | 1001-5000 | 1941 | Private |
Opsonin Pharma Ltd | Dhaka, Dhaka, Bangladesh | 5001-10000 | 1956 | Private |
MSD Switzerland | Lucerne, Lucerne, Switzerland | 1001-5000 | 1963 | Private |
Cadila Pharmaceuticals Limited | Ahmedabad, Gujarat, India | 5001-10000 | 1951 | Corporate |
Laboratório Cristália | Itapira, Sao Paulo, Brazil | 5001-10000 | 1972 | Private |
Aristopharma Ltd. | Dhaka, Dhaka, Bangladesh | 1001-5000 | 1986 | Private |
Douglas Pharmaceuticals | Auckland, Auckland, New Zealand | 501-1000 | 1967 | Family Owned |
Adamed Pharma | Warsaw, Masovian Voivodeship, Poland | 1001-5000 | 1986 | Private |
GSK Canada | Mississauga, Ontario, Canada | 1001-5000 | 1906 | Private |
Blau Farmacêutica | Cotia, Sao Paulo, Brazil | 1001-5000 | 1987 | Private |
Want to Find More Pharmaceuticals Companies?
If you want to find more companies that offer a broad range of medicines and healthcare solutions you can do so with Inven. This list was built with Inven and there are hundreds of companies like these globally.With Inven you'll also get to know the company's:- Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
- Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
- Financials: How do these companies perform financially? What are their revenues and profit margins?
...and a lot more!
Trusted by 700+ companies

















